Acrux Ltd has released a press release.
Investor Presentation February 2025
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Acrux
- Appendix 4D and December 2024 Half Year Accounts
- Acrux CEO announces plan to retire
- Monthly Activities/Appendix 4C Cash Flow Report
- Launch of 90 gram pack size of Dapsone 5%, Gel in US
- Acrux raises $1.34 million from SPP
Later from Acrux
- Acrux receives $1.73m advance on FY25 R&D Tax Incentive
- Acrux CEO and Managing Director appointment
- Dapsone 7.5%, Gel launched in the United States
- Receipt of second advance for FY25 R&D Tax Incentive
- Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux